Clinical Trial Update: Impact of Oral Magnesium on Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating oral magnesium for neuropathic pain has completed. The sponsor is University Hospital, Clermont-Ferrand.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Patient With Neuropathic Pain | Phase 4 | Status: COMPLETED